{"id":"W2118615533","doi":"10.1056/nejmoa1110899","title":"Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":545,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Eisai; Sanofi; LEO Pharma; Bayer HealthCare; GlaxoSmithKline; Pfizer; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Apixaban; Medicine; Intensive care medicine; Venous thromboembolism; Internal medicine; Rivaroxaban; Thrombosis; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002673775,0.0006864288,0.002159907,0.0003327334,0.0003203728,0.0008615071,0.0004476962,0.001237277,0.004757371],"category_scores_gemma":[0.004672683,0.0003444814,0.001353326,0.000227224,0.0008170514,0.000723749,0.0003581381,0.001503899,0.0003261819],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003628033,"about_ca_system_score_gemma":0.0007511249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002102408,"about_ca_topic_score_gemma":0.0004108186,"domain_scores_codex":[0.9984921,0.0009738111,0.0001855512,0.0001491627,0.00009456814,0.0001048345],"domain_scores_gemma":[0.9974475,0.001208544,0.0006908882,0.00008568385,0.00008031462,0.0004871605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9727734,0.002176906,0.00140937,0.0007524471,0.0006203215,0.00003876649,0.00005166586,0.0002036328,0.001628229,0.0002058992,0.0003151241,0.01982422],"study_design_scores_gemma":[0.855197,0.1348384,0.005951998,0.0001674525,0.0009319799,0.00006914671,0.00004122546,0.0009328997,0.0005750202,0.0003543866,0.0009221436,0.00001838747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9778839,0.01639182,0.0005463683,0.001422202,0.0009021665,0.001026876,0.0002130958,0.00003588285,0.001577647],"genre_scores_gemma":[0.9926895,0.003358907,0.0008082095,0.0008428735,0.0007793116,0.0009332167,0.0001104674,0.000003735891,0.0004738779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004757371,"threshold_uncertainty_score":0.01591498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05117862459668716,"score_gpt":0.2903365576645683,"score_spread":0.2391579330678811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}